Ampio Pharmaceuticals Liabilities 2024

Ampio Pharmaceuticals Aktienanalyse

What does Ampio Pharmaceuticals do?

Ampio Pharmaceuticals Inc is a biopharmaceutical company specialized in developing and marketing novel therapies for various diseases. The company was founded in 2010 and is headquartered in Englewood, Colorado. The history of Ampio Pharmaceuticals began with a goal: to realize the vision of developing innovative therapies that benefit patients. The founding idea focused on the development of a new therapy for osteoarthritis. Over time, however, the company diversified and specialized in the development of drugs for other areas such as diabetes, eye diseases, and pneumonia. Ampio Pharmaceuticals' business model is focused on cutting-edge technologies and scientific knowledge. The company employs an integrative approach that utilizes a variety of techniques, including cell-based therapies, gene therapies, and drug development. The company's core competencies lie in research, development, and marketing of innovative therapy options. Ampio Pharmaceuticals is divided into various business units. For example, the company is engaged in the development of drugs based on AMPio technologies. These compounds form the core of the therapy approaches and have already shown promising results in clinical trials. The company also emphasizes collaboration with partners to expedite the development of new therapy options. Another focus of Ampio Pharmaceuticals is the development of therapies for osteoarthritis. The company has developed a range of therapeutics targeting various aspects of the disease, such as anti-inflammatory agents and substances for joint cartilage regeneration. These therapies aim to alleviate the symptoms of osteoarthritis and provide patients with a higher quality of life. In addition to developing new therapy options, Ampio Pharmaceuticals also conducts clinical trials. These studies are designed to test the efficacy and safety of the developed drugs. Ampio Pharmaceuticals is committed to providing the highest standard of medical care by substantiating the safety and efficacy of their drugs through clinical trials. As a company specialized in drug development, Ampio Pharmaceuticals has launched a number of products on the market. These include Ampion, an injectable therapy for knee osteoarthritis, and Optina, an orally administered drug for the treatment of diabetes-related retinopathy. Overall, Ampio Pharmaceuticals is an innovative company specializing in the development of new therapy options. The company leverages modern technologies and scientific knowledge and aims to improve patients' lives through highly effective therapies. Ampio Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Ampio Pharmaceuticals's Liabilities

Ampio Pharmaceuticals's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Ampio Pharmaceuticals's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Ampio Pharmaceuticals's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Ampio Pharmaceuticals's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Ampio Pharmaceuticals’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Ampio Pharmaceuticals stock

What is the level of liabilities of Ampio Pharmaceuticals this year?

Ampio Pharmaceuticals has a debt balance of 2.38 M USD this year.

What were the liabilities of Ampio Pharmaceuticals compared to the previous year?

The liabilities of Ampio Pharmaceuticals have increased by 32% increased compared to the previous year.

What are the consequences of high debt for investors of Ampio Pharmaceuticals?

High liabilities can pose a risk for investors of Ampio Pharmaceuticals, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Ampio Pharmaceuticals?

Low liabilities mean that Ampio Pharmaceuticals has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Ampio Pharmaceuticals affect the company?

An increase in liabilities of Ampio Pharmaceuticals can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Ampio Pharmaceuticals affect the company?

A decrease in the liabilities of Ampio Pharmaceuticals can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Ampio Pharmaceuticals?

Some factors that can influence the liabilities of Ampio Pharmaceuticals include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Ampio Pharmaceuticals so important for investors?

The liabilities of Ampio Pharmaceuticals are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Ampio Pharmaceuticals take to modify the liabilities?

To change its liabilities, Ampio Pharmaceuticals can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Ampio Pharmaceuticals pay?

Over the past 12 months, Ampio Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Ampio Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Ampio Pharmaceuticals?

The current dividend yield of Ampio Pharmaceuticals is .

When does Ampio Pharmaceuticals pay dividends?

Ampio Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Ampio Pharmaceuticals?

Ampio Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Ampio Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Ampio Pharmaceuticals located?

Ampio Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Ampio Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Ampio Pharmaceuticals from 11/5/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/5/2024.

When did Ampio Pharmaceuticals pay the last dividend?

The last dividend was paid out on 11/5/2024.

What was the dividend of Ampio Pharmaceuticals in the year 2023?

In the year 2023, Ampio Pharmaceuticals distributed 0 USD as dividends.

In which currency does Ampio Pharmaceuticals pay out the dividend?

The dividends of Ampio Pharmaceuticals are distributed in USD.